Log in to search using one of your social media accounts:

 

HRT can slow decline in lung function for middle-aged women

(European Lung Foundation) Hormone replacement therapy (HRT) can slow the decline in lung function in middle-aged women, according to new research to be presented at the European Respiratory Society International Congress.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

It’s not going to kill you to take hormone replacement therapy. That’s the take home message from the latest analysis of the Women’s Health Initiative, the largest and longest randomized trial of hormone replacement therapy (HRT) in menopausal women. After almost 18 years of follow up in the WHI, there was no increase in overall mortality, including death rates from cancer, in women taking HRT for up to 5.6 years (estrogen plus progestin) or 7.2 years (estrogen alone). There was a non-significant reduction in mortality among those who started HRT between ages 50 and 59, the group most likely to ...
Source: The Blog That Ate Manhattan - Category: Primary Care Authors: Tags: Hormone Replacement Menopause WHI breast cancer estrogen HRT Prempro Source Type: blogs
(Natural News) Hormone replacement therapy is often touted for any number of things; these kinds of drugs are often given to women under the guise of reducing heart disease risk and minimizing the effects of menopause, for example. But are they really safe? While hormone replacement therapy (HRT) first gained popularity for reducing signs of...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
CONCLUSIONS: Fewer than half of all women received counseling and/or a prescription for HRT after diagnoses of iatrogenic menopause, and disparities were noted based on insurance status. These findings reflect a need for clearer guidelines on HRT during survivorship and improved efforts to reduce disparities in the distribution of survivorship care. PMID: 28923411 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Tags: Gynecol Oncol Source Type: research
Hormone replacement therapy  is not associated with all-cause, cancer or cardiovascular death, according to the results of an 18-year follow-up study.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
Follow-up to alarming reports issued at turn of century says women on therapy do not die sooner than those on placebosWomen will be able to take hormone replacement pills without worrying that the therapy will shorten their lifespans, according to the longest follow-up yet of research that raised fears about the risks of a once-popular treatment.That earlier research was stopped early when unexpected harm was found to be caused by the use of hormone replacement therapy (HRT) – oestrogen alone or in combination with progestin, a synthetic hormone.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Menopause Medical research Health Cancer & wellbeing Society Science World news Source Type: news
The pendulum has swung from one extreme to the other when it comes to hormone replacement therapy (HRT) to treat symptoms of menopause. At first, the replacement hormones—mostly a combination of estrogen and progestin to replace what the body stops making after menopause—were seen as a panacea. Doctors thought they could not only relieve hot flashes and night sweats, but also prevent chronic aging diseases like heart problems and weakening bones. But studies then found that the supplement hormones could lead to a higher risk of breast cancer—and that they didn’t protect the heart after all. In the l...
Source: TIME.com: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized Drugs estrogen Hormone Therapy hormones for menopause hot flashes night sweats progestin Reproductive Health treating menopause Source Type: news
Osteoporosis increases with age, most frequently in postmenopausal women because of reduced ovarian hormone levels. Furthermore, estrogen deficiency impairs trabecular metaphyseal bone. Although efficacious, long-term hormone replacement therapy (HRT) has estrogen-like side effects including breast and endometrial cancers, and non-hormonal or herbal therapies may be safer alternatives. Therefore, the aim of this study was to investigate the effects of aqueous extracts ofCynanchum wilfordii (CWW) on receptor activator of nuclear factor- κ B (NF-κ B) ligand (RANKL)-induced osteoclast differentiationin vitro and o...
Source: International Journal of Phytomedicine - Category: Science Authors: Source Type: research
Osteoporosis increases with age, most frequently in postmenopausal women because of reduced ovarian hormone levels. Furthermore, estrogen deficiency impairs trabecular metaphyseal bone. Although efficacious, long-term hormone replacement therapy (HRT) has estrogen-like side effects including breast and endometrial cancers, and non-hormonal or herbal therapies may be safer alternatives. Therefore, the aim of this study was to investigate the effects of aqueous extracts ofCynanchum wilfordii (CWW) on receptor activator of nuclear factor- κ B (NF-κ B) ligand (RANKL)-induced osteoclast differentiationin vitro and o...
Source: International Journal of Phytomedicine - Category: Science Authors: Source Type: research
In this study, we sought to determine the beneficial effects of a bioavailable isoflavone and probiotic treatment against postmenopausal osteopenia. Design: We used a novel red clover extract (RCE) rich in isoflavone aglycones and probiotics to concomitantly promote uptake and a favorable intestinal bacterial profile to enhance isoflavone bioavailability. This was a 12-mo, double-blind, parallel design, placebo-controlled, randomized controlled trial of 78 postmenopausal osteopenic women supplemented with calcium (1200 mg/d), magnesium (550 mg/d), and calcitriol (25 μg/d) given either RCE (60 mg isoflavone aglycones/d a...
Source: American Journal of Clinical Nutrition - Category: Nutrition Authors: Tags: Dietary Bioactive Compounds Research Articles Bone metabolism Source Type: research
Conclusion: These data indicate that TBBPA, triclosan, and BPA interact in vivo, consistent with evidence that TBBPA and triclosan inhibit enzymes that are critical for BPA and E2 metabolism. https://doi.org/10.1289/EHP1329 Received: 04 November 2016 Revised: 11 April 2017 Accepted: 13 April 2017 Published: 21 August 2017 Address correspondence to D. deCatanzaro, Dept. of Psychology, Neuroscience &Behaviour, McMaster University, 1280 Main St. West, Hamilton ON L8S 4K1, Canada. Telephone: (905) 525-9140, ext. 23014. Email: decatanz@mcmaster.ca Supplemental Material is available online (https://doi.org/10.1289/EHP1...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Hormone Replacement Therapy | Hormones | Politics | Respiratory Medicine | Women